Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK598809 for Smoking Relapse Prevention
NCT00793468Phase 2Withdrawn
- Sponsor
- GSK
- Start
- Dec 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK598809 in nicotine dependence, sponsored by GSK. Planned start Dec 2008; status: withdrawn.
02
Drugs
GSK598809
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00793468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00793468.